Q4 2020 Vanda Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Q4 2020 Vanda Pharmaceuticals, Inc. Earnings Conference Call.
(Operator Instructions)
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Kevin Moran, Vanda's Chief Financial Officer. Thank you. Please go ahead.
Thank you, Sadie. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' fourth quarter and full year 2020 performance. Our fourth quarter and full year 2020 results were released this afternoon and are available on the SEC's EDGAR system and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihales Polymeropoulos, our President and CEO. Following my introductory remarks, Mihales will update you on our ongoing activities. I will then
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |